 | |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral (tablets) |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII |
|
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.127 |
| Chemical and physical data | |
| Formula | C12H16N2O3 |
| Molar mass | 236.271 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Cyclobarbital,cyclobarbitol orcyclobarbitone is abarbituratederivative developed in the early 1970s in theSoviet Union.[2]
It was available inRussia until 2019,marketed and distributed asReladorm, afixed-dose combination pairing 100 mg cyclobarbital and 10 mgdiazepam (abenzodiazepineanxiolytic,muscle relaxant, andanticonvulsant) indicated for treatinginsomnia before it was discontinued in 2019.
